Intravenous pamidronate for treatment of osteogenesis imperfecta in Indian children

被引：2

作者：

Shah, Ira ^{[1
]}

Goel, Akshat ^{[2
]}

Shetty, Naman S. ^{[2
]}

Johari, Ashok ^{[3
]}

机构：

[1] Nananvati Hosp, Dept Pediat, Mumbai, Maharashtra, India

[2] BJ Wadia Hosp Children, Dept Pediat, Mumbai, Maharashtra, India

[3] Nanavati Hosp, Dept Pediat Orthoped, Mumbai, Maharashtra, India

来源：

TROPICAL DOCTOR | 2021年 / 51卷 / 02期

关键词：

Intravenous bisphosphonates; pamidronate; osteogenesis imperfecta; India;

D O I：

10.1177/0049475520982694

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Osteogenesis imperfecta is characterised by low bone mineral density, bone fragility, fractures and deformity. We present five such children treated with intravenous pamidronate, which resulted in a decrease of fracture rate and increase in spinal bone mineral density.

引用

页码：271 / 274

页数：4

共 10 条

[1] Clinical Review: Bisphosphonate Use in Childhood Osteoporosis [J].

Bachrach, Laura K. ;

Ward, Leanne M. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (02) :400-409

[2] Brief report: Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta [J].

Barnes, Aileen M. ;

Cliang, Weizhong ;

Morello, Roy ;

Cabral, Wayne A. ;

Weis, MaryAnn ;

Eyre, David R. ;

Leikin, Sergey ;

Makareeva, Elena ;

Kuznetsova, Natalia ;

Uveges, Thomas E. ;

Ashok, Aarthi ;

Flor, Armando W. ;

Mulvihill, John J. ;

Wilson, Patrick L. ;

Sundaram, Usha T. ;

Lee, Brendan ;

Marini, Joan C. .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (26) :2757-2764

[3] Two-year clinical trial of oral alendronate versus intravenous pamidronate in children with osteogenesis imperfecta [J].

DiMeglio, LA ;

Peacock, M .

JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 (01) :132-140

[4] Bisphosphonate therapy for osteogenesis imperfecta [J].

Dwan, Kerry ;

Phillipi, Carrie A. ;

Steiner, Robert D. ;

Basel, Donald .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (07)

[5] Cyclic administration of pamidronate in children with severe osteogenesis imperfecta [J].

Glorieux, FH ;

Bishop, NJ ;

Plotkin, H ;

Chabot, G ;

Lanoue, G ;

Travers, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (14) :947-952

[6] Vertebral morphometry in children and adolescents with osteogenesis imperfecta: Effect of intravenous pamidronate treatment [J].

Land, Christof ;

Rauch, Frank ;

Munns, Craig F. ;

Sahebjam, Solmaz ;

Glorieux, Francis H. .

BONE, 2006, 39 (04) :901-906

[7] Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate [J].

Lindahl, K. ;

Kindmark, A. ;

Rubin, C. -J. ;

Malmgren, B. ;

Grigelioniene, G. ;

Soderhall, S. ;

Ljunggren, O. ;

Astrom, E. .

BONE, 2016, 87 :11-18

[8] Genetic epidemiology, prevalence, and genotype-phenotype correlations in the Swedish population with osteogenesis imperfecta [J].

Lindahl, Katarina ;

Astrom, Eva ;

Rubin, Carl-Johan ;

Grigelioniene, Giedre ;

Malmgren, Barbro ;

Ljunggren, Osten ;

Kindmark, Andreas .

EUROPEAN JOURNAL OF HUMAN GENETICS, 2015, 23 (08) :1042-1050

[9] Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years [J].

Palomo, Telma ;

Fassier, Francois ;

Ouellet, Jean ;

Sato, Atsuko ;

Montpetit, Kathleen ;

Glorieux, Francis H. ;

Rauch, Frank .

JOURNAL OF BONE AND MINERAL RESEARCH, 2015, 30 (12) :2150-2157

[10] Oral bisphosphonate treatment for osteogenesis imperfecta - an Indian perspective [J].

Shah, Ira ;

Johari, Ashok .

ANNALS OF TROPICAL PAEDIATRICS, 2007, 27 (01) :39-43

← 1 →